Drug Shortage Report for SANDOZ OLANZAPINE ODT
Report ID | 45809 |
Drug Identification Number | 02327775 |
Brand name | SANDOZ OLANZAPINE ODT |
Common or Proper name | OLANZAPINE |
Company Name | SANDOZ CANADA INCORPORATED |
Market Status | MARKETED |
Active Ingredient(s) | OLANZAPINE |
Strength(s) | 5MG |
Dosage form(s) | TABLET (ORALLY DISINTEGRATING) |
Route of administration | ORAL |
Packaging size | BLISTERS 30S |
ATC code | N05AH |
ATC description | ANTIPSYCHOTICS |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | 2018-04-16 |
Actual start date | |
Estimated end date | 2018-07-06 |
Actual end date | 2018-04-16 |
Shortage status | Resolved |
Updated date | 2018-04-19 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 110 RUE DE LAUZON BOUCHERVILLE, QUEBEC CANADA J4B 1E6 |
Company contact information | 1 800-361-3062 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v5 | 2018-04-19 | French | Compare |
v4 | 2018-04-19 | English | Compare |
v3 | 2018-04-17 | English | Compare |
v2 | 2018-04-13 | French | Compare |
v1 | 2018-04-13 | English | Compare |
Showing 1 to 5 of 5